Medicine Information

Bextra and Vioxx Withdrawal Spurs Price Increase Among Rivals


The market for painkillers is huge. People don't like pain and inflammation, and last year Americans spent nearly $4 billion on just two of them - Vioxx and Bextra. Those two drugs, part of a family of non-steroidal anti-inflammatory drugs known as COX-2 inhibitors, were withdrawn from the market recently amid concerns that they can cause heart attacks and strokes. The loss of these two drugs to the marketplace is huge, as they were the two largest sellers in a fairly narrow field. COX-2 inhibitors differ from traditional non-steroidal anti-inflammatory drugs in that they inhibit production of the COX-2 enzyme that causes inflammation but do not interfere with COX-1, the enzyme that protects the stomach lining. Patients who use these drugs are thought to suffer less from internal discomfort and bleeding than those who took traditional anti-inflammatories, such as naproxen and ibuprofen.

With the withdrawal of these two blockbusters, patients with chronic pain, such as arthritis sufferers, are now going back to older painkillers, such as Mobic, Motrin, and Relafen. Since the more popular Vioxx and Bextra are no longer available, these older drugs are enjoying a resurgence in popularity, and sales are up across the board. So, it seems, are their prices. A recent study by a popular consumer publication shows that prices of some three dozen anti-inflammatory medications have gone up since Vioxx was withdrawn from the market in September 2004. The increases average about ten percent. Why have the prices of these older, established medications all gone up at once?

The answer, simply, is that the pharmaceutical companies have raised the prices because they can. The market for drugs is wildly competitive, and manufacturers are constantly seeking any advantage they can find in the marketplace. The sudden withdrawal of two of the most popular and profitable medications has provided a rare opportunity for manufacturers to increase both sales and prices at the same time, as the drug makers know that patients must switch to another medication. It's good for their stockholders, but bad for those who suffer from pain.

Will the high prices last? Probably not. Pricing of highly competitive medications tends to be volatile. The prices may stay up in the short term, but other medications may be introduced soon, or Bextra or Vioxx may be returned to the market. The introduction of other drugs will restore more competition to the market, and prices may drop once again. The market for painkilling drugs is a bit of a crazy one, and patients should simply exhibit some, well, patience.

©Copyright 2005 by Retro Marketing.

Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.


MORE RESOURCES:
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news


Science Daily

Distinct human mutations can alter the effect of medicine
Science Daily
By mining existing data sets they have mapped the extent to which mutations occur within GPCR drug targets in individuals and studied what impact these mutations could have on the therapeutic effect of medicine. "We estimate that an average of 3 ...

and more »


UCSF News Services

2018 Precision Medicine World Conference to Feature UCSF Faculty
UCSF News Services
For the third consecutive year, UC San Francisco is co-sponsoring the Precision Medicine World Conference (PMWC) in January 2018 to share the latest in the rapidly evolving space. Renamed from the Personalized Medicine World Conference, the annual ...



International Atomic Energy Agency

Remarks at Conclusion of International Conference on Radiation Protection in Medicine
International Atomic Energy Agency
I understand that it has been a productive meeting. I thank all of you for taking part and sharing your insights and experience in this very important area. Nuclear and radiation safety is a national responsibility, but the IAEA's 168 Member States ...



Healthcare IT News

Siemens Healthineers buys Fast Track Diagnostics for precision medicine tech
Healthcare IT News
Adding Fast Track Diagnostics molecular-testing technologies enables hospitals to target conditions such as respiratory infections, gastroenteritis, meningitis, hepatitis, infections of the immunosuppressed, tropical diseases, sexually transmitted ...

and more »


Newsweek

History of Medicine: Ancient Poop Reveals Parasitic Worms Described by Hippocrates 2500 Years Ago
Newsweek
Researchers studying prehistoric poop on the Greek island of Kea have finally identified the parasitic worms that Hippocrates, the ancient Greek physician widely considered the father of modern medicine, described in his famous medical texts 2,500 ...

and more »


Mirror.co.uk

Why you should never take cough medicine when you're ill
Mirror.co.uk
Coughs and colds are rampant in the UK at the moment after a sudden turn in the weather. People probably regretted playing in all that snow as soon as they started sneezing. And in the run-up to Christmas, desperate to be well for the festive season ...



Personalized Medicine Faces 4 Key Challenges in the US Marketplace
AJMC.com Managed Markets Network
The landscape for the regulation of personalized medicine is still in its infancy. Despite the FDA's strides in producing draft guidance and other documents that concern a regulatory pathway for personalized medicine diagnostics (such as the 2017 ...



Washington University School of Medicine in St. Louis

Study prompts new ideas on cancers' origins
Washington University School of Medicine in St. Louis
“As scientists, we have focused a good deal of attention on understanding the role of stem cells in the development of cancers, but there hasn't been a focus on mature cells,” said senior investigator Jason C. Mills, MD, PhD, a professor of medicine in ...

and more »


Science Trends

The Missing Link For Effective Regenerative Medicine: A Novel Source Of Highly Differentiable Stem Cells
Science Trends
Finding a reliable source of cells with wide differentiation capacity in adult organisms would provide a promising tool for regenerative medicine, specifically in facilitating autologous treatment. Mesenchymal stem cells (MSCs) are classified as ...

and more »


KXLH Helena News

Medicine Springs Mineral Therapy makes Top 10 list
KXLH Helena News
Medicine Springs Mineral Therapy, a Montana business featured last year in our weekly Montana Made segment, has been named one of the best products of 2017 by a national publication. Vitamin Retailer Magazine named Medicine Springs Mineral Therapy to ...

and more »

Google News

home | site map | Dr. Thad Thomas
© 2006